Skip Navigation

Rheumatology 2005 44(3):402-403; doi:10.1093/rheumatology/keh509
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stevens, R. J.
Right arrow Articles by Bowman, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, R. J.
Right arrow Articles by Bowman, S. J.
Related Collections
Right arrow Sjogren's Syndrome
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 44 No. 3 © British Society for Rheumatology 2005; all rights reserved

LETTER TO THE EDITOR

Flares of systemic disease in primary Sjögren's syndrome

R. J. Stevens, J. Hamburger1, J. R. Ainsworth2, G. Holmes3 and S. J. Bowman3

Birmingham Heartlands Hospital, Rheumatology Department, 1 Birmingham Dental Hospital and School, Department of Oral Medicine, 2 Birmingham Heartlands Hospital, Ophthalmology Department, 3 University Hospital Birmingham, Rheumatology Department, Birmingham, UK

Correspondence to: S. J. Bowman. E-mail: s.j.bowman@bham.ac.uk

The first 10% of the full text of this article appears below.

SIR, Rheumatic disorders such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) are characterized by a relapsing–remitting course, with flares of disease activity [1, 2] amenable to therapy. This has not been well studied for the systemic features of primary Sjögren's syndrome (PSS). We report our observations from 59 consecutive patients with PSS, fulfilling the revised EU–USA criteria [3], who attended a multidisciplinary Sjögren's syndrome clinic in Birmingham, UK between 1 January 1997 and 31 December 2001. Six further . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?